Large-Scale Prevalence Set to Favor Halitosis Market Proliferation over 2023

Pune, India, September, 2018 /press release/- Market Research Future Published a Cooked Research Report on Halitosis Market Research Report.

Market Insights:

Market Research Future (MRFR)’s recently published report on the global halitosis market reveals that the market is set to witness a sharp rise in growth striking a CAGR of 18.58% during the forecast period 2017 to 2023. The market has been forecasted to reach a valuation of USD 22,153.4 Bn by the end of 2023.

One of the key factors propelling the growth of the market is the rising burden of chronic diseases. Chronic diseases such as cancer are major reasons responsible for the causing halitosis. Furthermore, the increasing incidences of periodontal diseases in another crucial factor accelerating the revenue creation for halitosis market players.

The increasing awareness about the treatment coupled with a shift towards oral hygiene has opened avenues of growth opportunities in the market. The trend is anticipated to perpetuate over the next couple of years. The innovative range of product offerings is the key area of focus for the halitosis industry leaders. The availability of different products for the treatment of halitosis is another factor favoring the growth and expansion of the market. Additionally, the exponential geriatric population is likely to augur well for the halitosis market operators as older adults are often affected by the disease.

Market Segmentation:

By type, the halitosis market is segmented into pathological halitosis and others.

By indication, the global halitosis market has been segmented into respiratory, liver, kidney, gastrointestinal, systemic, and others.

By diagnostic test, the halitosis market is segmented into halimeter, gas chromatography, BANA test, β-galactosidase activity assay, and others.

By drug treatment, the global halitosis treatment market has been segmented into antacids, antiseptic, ranitidine and others.

Access Report @ https://www.marketresearchfuture.com/reports/halitosis-treatment-market-3758

Regional Analysis

By region, the global halitosis market has been segmented into America, Europe, Asia Pacific, and Middle East & Africa. Americas is set to hold a significant share of the market owing to the large-scale prevalence of gum diseases and increasing demand for oral care products. According to a report, approximately USD 810 Mn was spent on halitosis treatment in the U.S. in 2013.

Europe currently accounts for the second largest share of the global halitosis market. It is likely to exhibit positive growth during the forecast period. The growth is attributable to the increase in awareness regarding halitosis coupled with a widening range of products being offered for its treatment.

Asia Pacific is expected to witness a steep rise in the growth of the halitosis market. The factors responsible for aiding the market proliferation in the region are the prevalence of chronic diseases, rising geriatric population, etc. Meanwhile, the Middle East & Africa region is expected to exhibit sluggish growth due to lack of awareness about oral healthcare and poor economic conditions in African regions.

Competitive Dashboard:

Some of the key players profiled in the report are Colgate-Palmolive Company (U.S.), Rowpar Pharmaceuticals, Inc. (U.S.), Abbott (U.S.), All USA Partners LLC (U.S.), Dr. Harold Katz, LLC (U.S.), Listerine (U.S.), and AstraZeneca (U.S.) among others.

Industry Developments:

In May 2018, toiletries maker Lion has launched a smartphone application using artificial intelligence to gauge halitosis intensity based on images of the tongue.

In August 2018, Oralogica, first organic personal care product company, launched its line of organic and natural oral care products including products for treating halitosis.